Advanced in Interstitial Nephritis

Fiona M. Smaill

Hamilton, ON, CA 
Advanced in Interstitial Nephritis
Hamilton, ON, CA 
OverviewLocationsClinical Research

Overview

Fiona Smaill practices in Hamilton, Canada. Ms. Smaill is rated as an Advanced expert by MediFind in the treatment of Interstitial Nephritis. Her top areas of expertise are HIV/AIDS, Human Papillomavirus Infection, Asymptomatic Bacteriuria, and Interstitial Nephritis.

Her clinical research consists of co-authoring 60 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Interstitial Nephritis.

Gender
Female

Locations

Hamilton, ON, Canada
Other Locations
Hamilton, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase 1, Open Label Study to Evaluate the Safety and Immunogenicity of ChAd68 and AdHu5 Vector-based Trivalent COVID-19 Vaccines Delivered Via Inhaled Aerosol
Phase 1, Open Label Study to Evaluate the Safety and Immunogenicity of ChAd68 and AdHu5 Vector-based Trivalent COVID-19 Vaccines Delivered Via Inhaled Aerosol
Enrollment Status: Completed
Publish Date: July 17, 2025
Intervention Type: Biological
Study Phase: Phase 1
Bone Health in Aging HIV Infected Women: Improvement or Prevention of Changes in Bone Mineral Density by Switching Antiretroviral Agents. Is There an Optimal Time to Intervene?
Bone Health in Aging HIV Infected Women: Improvement or Prevention of Changes in Bone Mineral Density by Switching Antiretroviral Agents. Is There an Optimal Time to Intervene?
Enrollment Status: Completed
Publish Date: December 19, 2024
Intervention Type: Drug
Study Drugs: tenofovir-alafenamide-emtricitabine, tenofovir-emtricitabine
Study Phase: Phase 4
Phase 1, Open-label Clinical Trial to Evaluate the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine Administered by Aerosol
Phase 1, Open-label Clinical Trial to Evaluate the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine Administered by Aerosol
Enrollment Status: Completed
Publish Date: November 01, 2021
Intervention Type: Biological
Study Phase: Phase 1
View 2 Less Clinical Trials

60 Total Publications

The association between HIV drug resistance testing, viral suppression and mortality in Ontario: a retrospective cohort study.
The association between HIV drug resistance testing, viral suppression and mortality in Ontario: a retrospective cohort study.
Journal: HIV medicine
Published: March 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Smaill's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile